Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

Ekso Bionics Holdings, Inc. (EKSO)

Add EKSO Price Alert      Hide Sticky   Hide Intro
Moderator: skepticone, Lion33, Rhetorical
Search This Board: 
Last Post: 12/15/2017 6:21:11 PM - Followers: 106 - Board type: Free - Posts Today: 26

Industry leaders in healthcare, military, and industrial exoskeletons 
                                         (Continue below to message board)                                  


Ekso GT (Healthcare):

Ekso GT is a robotic exoskeleton used for over-ground gait training in people with a neurological diagnosis. It helps patients re-learn the correct step patterns and weight shifts involved in walking, potentially mitigating compensatory behaviors.

Ekso GT’s Variable Assist software allows physical therapists to determine how much power is provided to either side of the person’s body. This balances the physical effort that the person exerts with the amount of help that he or she needs to achieve a more normalized gait. It also makes the device suitable for a broad spectrum of neuro-rehabilitation activities and keeps individuals challenged as they progress through their rehabilitation.

For people who thought they would never stand or walk again, Ekso GT provides hope for greater mobility and independence.

[Christina Kwasnica, M.D., medical director for the Barrow Neuro Rehabilitation Center, notes, “The robotic device allows us to get patients up on their feet earlier. The gains we see are overwhelming and the positive effects on a patient’s mood and motivation is unbelievable.”

Ekso Bionics(TM) Receives Its First NIH Grant (Oct 28, 2014):
RICHMOND, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.

Ekso Bionics Licences Intellectual Property to Ottobock (Nov 3, 2014):

Ekso GT™ Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients (Apr 4, 2016):

EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology (Jun 7, 2016):

Ekso Bionics® Launches Smart Assist (Oct 4, 2016):

Ekso Bionics® Launches EksoPulse Cloud-Based Analytics (Feb 9, 2017):

Ekso Bionics and Vodafone Receive 2016 HealthTechZone Telehealth Award (Apr 7, 2017):

Ekso: T.A.L.O.S. & Warrior Web (D.O.D.):

T.A.L.O.S. (Tactical Assault LIght Operator Suit):
Ekso Labs was awarded an Other Transaction for Prototypes Agreement from U.S. Special Operations Command (SOCOM) to develop technologies for their Tactical Assault Light Operator Suit (TALOS) project. TALOS is a futuristic assault suit that promises to provide superhuman strength with superior mobility and protection, and is often referred to as the "Iron Man" suit. The exoskeleton chassis, which Ekso Labs is developing, will be designed to allow soldiers to carry out their mission with agility, while carrying hundreds of pounds of load. The TALOS project is integrating other functional elements, including armor and systems, to provide situational awareness and technology for vital signs monitoring.

Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project

Ekso(TM) Labs Secures Third Contract With the U.S. Special Operations Command (SOCOM) for Upper Extremity TALOS Project (5/20/15)

Warrior Web Flexible Exoskeleton:
Ekso Bionics™ Selected for Development of Next-Generation DARPA Exoskeleton

Warrior Web A:
Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported.

Warrior Web B:

"Ekso Bionics (NASDAQ: EKSO), having successfully supplied technology to Warrior Web Task A, has been selected to participate in the second and concluding Warrior Web Task B.

Ekso Bionics will gain $4.5 million in the combined contract for both tasks." - RBR

Army R&D with RE2 Robotics:
(This is from a press release from RE2, not from Ekso Bionics. Ekso is simply jointly involved as mentioned below)
Note: EKSO is now on the NASDAQ exchange not the OTCBB

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."


EksoZeroG and Artemis (Construction/Tool Usage):


Ekso Bionics has spent several years designing and perfecting a range of ergonomic tool arms which are used to weightlessly manoeuvre heavy tools. These arms rely on spring tension and innovative design to balance the weight of tools used in drilling, sanding, riveting and many other applications. The Ekso Bionics Zero G arms are designed to hold loads of up to 19kg and fully balance the weight thus allowing the user to freely, safely and accurately manoeuvre the load in any direction without injury or fatigue.

The ergonomic tool arms have a variety of mounting options to suit the application including portable gantry’s, carts, jib arms, and linear rail. These systems require very little maintenance, no expensive inputs like electricity or compressed air, and have already been successfully used in a variety of industries from aerospace and defence to automotive manufacturing.

  • -Payback of less than a year
    -ROI of 100%
    -Less than 30 min of operator training required to achieve competency
    -No expensive inputs such as electricity or air required
    -Very minimal maintenance
    -Modular design for flexibility
    -13 different mobile and fixed mounting options
    -4 different arm configurations

There are several mounting options fro the Zero G ergonomic tool arms from ground based trolleys, to gantry mounts, jib crane mounts, linear rail and bench top mounting.

The Zero G ergonomic tool arm is used extensively in the aerospace,construction, mining and ship building industries in a range of roles. The weight balancing aspect of the Equipois Zero G system allows workers to grind, drill, chip surfaces easily for long periods of time even if the surface is in an overhead orientation.

Current users of the Equipois Zero G system include Airbus, Boeing, General Electric, BHP Billiton, Gammon Construction, Lockheed Martin, Chrysler, Ford, Honda, Nissan, Toyota, Caterpillar, John Deere, Bradken and many more.


Ekso Artemis:

"RICHMOND, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an exoskeleton company, today announced that it has completed the development of a lightweight, flexible load carriage exoskeleton prototype named Artemis."

Ekso Bionics Company Information:
-Founded in 2005 and headquartered in Richmond, CA 
--Originally Berkely Bionics of Univsity of California, Berkeley
-The current CEO is Thomas Loobyy
-Ekso is the industry leader in healthcare, military, and industrial exoskeletons
-The Ekso Bionics Ekso GT™ is the first and only FDA approved exoskeleton for stroke rehabiliation
-Over 190 international patent cases (granted or pending)

-Headquartered in the historic Ford Motor Company Assembly Plant, the largest wartime production assembly plant to be built on the West Coast
Company Presentation:

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested. There are no guarantees when buying or selling any security.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EKSO News: Current Report Filing (8-k) 12/14/2017 05:23:22 PM
EKSO News: Ekso Bionics® Partners with HASOMED to Launch Functional Electrical Stimulation (FES) for the EksoGT™ Exoskeleton 12/14/2017 08:00:00 AM
EKSO News: International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™ 11/28/2017 08:00:00 AM
EKSO News: Statement of Changes in Beneficial Ownership (4) 11/27/2017 04:14:09 PM
EKSO News: Report: Developing Opportunities within OGE Energy, Stratasys, Snap, J.C. Penney Company, Inc. Holding, Micron Technology, an... 11/27/2017 07:55:00 AM
#2381  Sticky Note On Talos: [continued "top level support" for the Rhetorical 08/16/16 07:02:33 PM
#4656   Agreed. However, when/if the float hits 400M PennyWorld 12/15/17 06:21:11 PM
#4655   This is far from reversing no doubt Lion33 12/15/17 04:36:29 PM
#4654   I was in for 3000 shares at about Lion33 12/15/17 04:34:41 PM
#4653   There won't be a reverse split if the golfblues 12/15/17 04:28:40 PM
#4652   As I said in a previous post...I am skepticone 12/15/17 04:28:23 PM
#4651   I’m watch closely and ready to add if Lion33 12/15/17 04:20:53 PM
#4650   If this can help a partially paralysis patient Lion33 12/15/17 04:19:40 PM
#4649   They may have a REAL commitment to the PennyWorld 12/15/17 04:18:38 PM
#4647   Have to agree with you. This stock never skepticone 12/15/17 04:08:59 PM
#4646   Lion.. Think what you wish. EKSO is losing PennyWorld 12/15/17 04:03:33 PM
#4644   Under lots of pressure to hold 2.30, next skepticone 12/15/17 03:53:56 PM
#4643   You keep asking questions until you hear the Lion33 12/15/17 03:44:58 PM
#4642   I don't expect another R/S until the float PennyWorld 12/15/17 03:37:11 PM
#4641   Lion.. look back. There was an R/S. PennyWorld 12/15/17 03:33:32 PM
#4640   You said reverse split. EKSO has less than Lion33 12/15/17 03:07:04 PM
#4639   I am a veteran of buying/selling penny stocks. PennyWorld 12/15/17 02:33:02 PM
#4638   Don't forget though. EKSO has competition. And PennyWorld 12/15/17 02:29:21 PM
#4637   How are you claiming ti be s veteran Lion33 12/15/17 02:22:15 PM
#4636   Wrong they know they have billion $ tech. packerfan9 12/15/17 01:51:26 PM
#4635   I bought some ekso recently and sold when Jgregsr 12/15/17 01:19:53 PM
#4634   Oh my! I'm a veteran with this, so PennyWorld 12/15/17 01:01:08 PM
#4633   Where are you coming up with this? Nothing Lion33 12/15/17 12:07:03 PM
#4632   EKSO will not run out of cash. They PennyWorld 12/15/17 10:10:09 AM
#4631   FES means upselling to current owners of the Rhetorical 12/15/17 02:25:15 AM
#4630   If FES cures paralysis, doesn't matter how old Rhetorical 12/14/17 11:48:37 PM
#4629   Thanks for the info, but my only reservation PennyWorld 12/14/17 07:43:58 PM
#4628   Thank you again, Rhet skepticone 12/14/17 07:25:05 PM
#4627   Essentially, the SEC doesn't say it's inaccurate - Rhetorical 12/14/17 06:56:09 PM
#4626   "Simply put, a material weakness is one or Rhetorical 12/14/17 06:09:22 PM
#4625   Rhet, what impact do you think this will skepticone 12/14/17 05:33:42 PM
#4624 skepticone 12/14/17 05:33:42 PM
#4623   Ekso Bionics® Partners with HASOMED to Launch Functional Rhetorical 12/14/17 04:30:23 PM
#4622   REMEMBER THIS IN RELATION TO FES: Rhetorical 12/14/17 04:29:15 PM
#4621   yes, but did the PPS capitulate on you PennyWorld 12/14/17 12:27:18 PM
#4620   It was done to uplist. I have confidence radly 12/13/17 10:09:43 PM
#4619   I wasn't around here for the last R/S. PennyWorld 12/13/17 09:48:52 PM
#4618   Was here pre split. So here at $6 radly 12/13/17 09:37:07 PM
#4617   Unless there is another R/S to pay the bills. PennyWorld 12/13/17 08:05:41 PM
#4616   Ted Wang will bring us above $5 is Rhetorical 12/13/17 07:54:36 PM
#4615   Radly... you most likely got in a little PennyWorld 12/13/17 07:18:27 PM
#4614   This stock has been so disappointing! Maybe it radly 12/13/17 06:27:58 PM
#4613   I still believe this is following the same skepticone 12/13/17 10:44:34 AM
#4612   Read first post about EKSO and Apple,have you RainerRocks 12/10/17 08:11:01 PM
#4611 RainerRocks 12/10/17 08:08:44 PM
#4610   INTERVIEW W/ ERGONOMICS DECISION MAKER AT FORD: Rhetorical 12/09/17 05:54:07 PM
#4609 Rhetorical 12/09/17 04:36:55 AM
#4608 Rhetorical 12/09/17 04:36:35 AM
#4607   EKSO BIONICS ON VERGE!!!!!! Rhetorical 12/09/17 04:19:14 AM
#4606   Ford or any company will be looking to packerfan9 12/07/17 06:39:13 PM
#4605   It might be better the union bought exoskeletons Rhetorical 12/07/17 06:18:05 PM